Quick Comparison

Bacopa MonnieriCordyceps
Half-Life2-6 hours (bacosides)Bioactive compounds accumulate with daily use
Typical DosageStandard: 300-600 mg daily of extract standardized to 50% bacosides (e.g., Bacognize or Synapsa). Take with fat for absorption. Allow 8-12 weeks for full effects. Evening dosing preferred due to mild sedation.Standard: 1000-3000 mg daily of Cordyceps militaris fruiting body extract. CS-4 mycelium: 1000-3000 mg daily. Cordycepin content varies by product. Take in the morning — may be mildly stimulating. Effects build over 1-2 weeks.
AdministrationOral (capsules, powder). Fat-soluble — take with a meal containing fat.Oral (capsules, powder, extract). Cordyceps militaris fruiting body preferred over CS-4 mycelium for cordycepin content.
Research Papers8 papers9 papers
Categories

Mechanism of Action

Bacopa Monnieri

Bacopa's bacosides (bacosides A and B, bacopaside I-VII) enhance synaptic communication by increasing dendritic branching, spine density, and synaptic activity in the hippocampus via modulation of neural cell adhesion molecules (NCAM) and FGF-2. They modulate serotonin through 5-HT3 receptor antagonism (reducing anxiety) and 5-HT2A modulation, dopamine through D1/D2 receptor modulation, and acetylcholine through enhancement of choline acetyltransferase. Bacosides upregulate tryptophan hydroxylase (TPH) and serotonin transporter (SERT) expression, increasing serotonin synthesis and reuptake. The antioxidant properties of bacosides reduce lipid peroxidation and protein carbonylation in the hippocampus via free radical scavenging, protecting neurons from oxidative damage during memory formation. They may enhance CREB phosphorylation and BDNF expression.

Cordyceps

Cordycepin (3'-deoxyadenosine), the primary bioactive compound, increases ATP production by enhancing mitochondrial electron transport chain efficiency — it may act as an alternative substrate or modulator of Complex I and Complex III. Cordycepin activates AMPK (AMP-activated protein kinase) via increased AMP/ATP ratio or direct activation of the alpha subunit, promoting glucose uptake through GLUT4 translocation and fatty acid oxidation via CPT-1 and ACC inhibition. Cordyceps increases erythropoietin (EPO) production, likely through HIF-1alpha stabilization in hypoxic-sensitive tissues, improving oxygen-carrying capacity. Cordycepin has adenosine-like activity, modulating purinergic P1 (A1, A2A, A2B, A3) and P2 receptors. Anti-inflammatory effects occur through inhibition of NF-kB (reducing IKK degradation of IkB and nuclear translocation) and reduction of pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). Adenosine deaminase-resistant cordycepin may also affect RNA polyadenylation.

Risks & Safety

Bacopa Monnieri

Common

Gastrointestinal discomfort (cramping, nausea, bloating), fatigue, dry mouth.

Serious

May interact with thyroid medications.

Rare

Increased bowel movements, decreased appetite.

Cordyceps

Common

Mild gastrointestinal discomfort, dry mouth.

Serious

May lower blood sugar — caution with diabetes medications. May increase bleeding risk.

Rare

Allergic reaction in mushroom-sensitive individuals.

Full Profiles